VANCOUVER, BC, June 16, 2023 /PRNewswire/ – WELL Health Technologies Corp. (TSX: WELL) (the “Company” or “WELL“), company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that at its annual general and special meeting held June 15, 2023 (the “Meeting“), all of the nominees for … Read more
HEFEI, China, 17. Juni 2023 /PRNewswire/ — TG ImmunoPharma Co., Ltd. (TGI), ein führendes Biotech-Unternehmen, das sich auf die Entwicklung neuartiger immunonkologischer Therapien spezialisiert hat, freut sich, bekannt zu geben, dass die FDA die Genehmigung der klinische Studie des TGI-6, seinem bahnbrechenden bispezifischen Antikörper, erteilt hat. TGI-6 zielt auf einzigartige tumorassoziierte Antigene (TAA) und gleichzeitig … Read more
DUBLIN, June 16, 2023 /PRNewswire/ — The “Dimethyl Sulfoxide (DMSO): Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Dimethyl Sulfoxide (DMSO) estimated at US$253 Million in the year 2022, is projected to reach a revised size of US$417.2 Million by 2030, growing at a CAGR of 6.5% over the analysis … Read more
VANCOUVER, BC, June 16, 2023 /PRNewswire/ – Asep Medical Holdings Inc. (“Asep Inc.” or the “Company”) (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is very pleased to announce it is preparing the final draft of its NASDAQ registration statement for its planned listing and trading of its common shares on the NASDAQ stock exchange. The Company has engaged … Read more
MULTICARE SHORTCHANGES PATIENT CARE BY HOLDING $2 BILLION IN PUBLICLY TRADED SECURITIES FEDERAL WAY, Wash., June 16, 2023 /PRNewswire/ — Providers at one of the largest Urgent Care Clinics in Washington are a step closer to a picket and going on strike. In a unanimous vote, doctors, nurse practitioners, and physician assistants voiced “No Confidence” … Read more
DUBLIN, June 16, 2023 /PRNewswire/ — The “Biopharma Perceptions of Global CRO Thought Leadership – 2023” report has been added to ResearchAndMarkets.com’s offering. The report examines perceptions of 120 professionals across emerging, small, mid-size and large biopharmaceutical companies in North America and Europe involved in outsourcing clinical development services to the leading, global CROs. This report … Read more
SUZHOU, China, June. 16, 2023 /PRNewswire/ — The 4th Academic Annual Conference held by the Mechanical Circulatory Support (MCS) Branch of the Chinese Society of Biomedical Engineering (CSBE), one of the biggest academic gatherings that celebrate the latest accomplishments in technological innovation for improving human health, witnessed the display of the MoyoAssist® Extra-VAD – a fully … Read more
DUBLIN, June 16, 2023 /PRNewswire/ — The “South Korea In-Vitro Diagnostics (IVD) Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Key Players Analysis, Government Initiatives, Recent Developments – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. South Korea In-Vitro Diagnostics (IVD) market is predicted to reach US$ 3.7 Billion by 2028 … Read more
DUBLIN, June 16, 2023 /PRNewswire/ — The “Extended Release Injectable Drugs” report has been added to ResearchAndMarkets.com’s offering. Chronic conditions require drug administration over long periods of time, placing a greater emphasis on self-administration. With the shift away from caregiver interaction, drug safety and compliance/adherence become prominent concerns. These concerns, which are not new, are becoming … Read more
A aprovação dessa droga, fruto da aquisição da Albireo, representa uma oportunidade de crescimento para a Ipsen e reforça o seu posicionamento no mercado de doenças raras São Paulo, 16 de junho de 2023 /PRNewswire/ — A Ipsen acaba de aprovar o Bylvay® (odevixubate) no Brasil e o seu registro foi publicado no Diário Oficial … Read more